187 related articles for article (PubMed ID: 36980311)
1. HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV).
Pawlowski T; Malyszczak K; Pawlak D; Inglot M; Zalewska M; Grzywacz A; Radkowski M; Laskus T; Janocha-Litwin J; Frydecka D
Cells; 2023 Mar; 12(6):. PubMed ID: 36980311
[TBL] [Abstract][Full Text] [Related]
2. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
[TBL] [Abstract][Full Text] [Related]
3. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-α 2a treatment.
Pawlowski T; Malyszczak K; Inglot M; Zalewska M; Radkowski M; Laskus T; Pawlak D
Psychoneuroendocrinology; 2018 Nov; 97():1-7. PubMed ID: 29990677
[TBL] [Abstract][Full Text] [Related]
5. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
6. Serotonin gene polymorphisms and lifetime mood disorders in predicting interferon-induced depression in chronic hepatitis C.
Cozzolongo R; Porcelli P; Cariola F; Giannuzzi V; Lanzilotta E; Gentile M; Sonnante G; Leandro G
J Affect Disord; 2015 Sep; 183():90-7. PubMed ID: 26001668
[TBL] [Abstract][Full Text] [Related]
7. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
8. Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.
Kraus MR; Al-Taie O; Schäfer A; Pfersdorff M; Lesch KP; Scheurlen M
Gastroenterology; 2007 Apr; 132(4):1279-86. PubMed ID: 17408646
[TBL] [Abstract][Full Text] [Related]
9. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.
Udina M; Navinés R; Egmond E; Oriolo G; Langohr K; Gimenez D; Valdés M; Gómez-Gil E; Grande I; Gratacós M; Kapczinski F; Artigas F; Vieta E; Solà R; Martín-Santos R
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26721949
[TBL] [Abstract][Full Text] [Related]
11. HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment.
Zignego AL; Cozzi A; Carpenedo R; Giannini C; Rosselli M; Biagioli T; Aldinucci A; Laffi G; Moroni F
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S107-11. PubMed ID: 17936210
[TBL] [Abstract][Full Text] [Related]
12. Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.
Flori N; Funakoshi N; Duny Y; Valats JC; Bismuth M; Christophorou D; Daurès JP; Blanc P
Drugs; 2013 Mar; 73(3):263-77. PubMed ID: 23436591
[TBL] [Abstract][Full Text] [Related]
13. Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.
Vispo E; Barreiro P; Rodriguez-Nóvoa S; Morello J; Labarga P; Martín-Carbonero L; Maida I; García-Gascó P; Soriano V
Antivir Ther; 2008; 13(4):511-7. PubMed ID: 18672529
[TBL] [Abstract][Full Text] [Related]
14. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Verkerk R; Meltzer H; Maes M
J Clin Psychopharmacol; 2002 Feb; 22(1):86-90. PubMed ID: 11799348
[TBL] [Abstract][Full Text] [Related]
15. Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.
Escudero A; Rodríguez F; Serra MA; Del Olmo JA; Montes F; Rodrigo JM
J Gastroenterol Hepatol; 2008 Jun; 23(6):861-6. PubMed ID: 18422960
[TBL] [Abstract][Full Text] [Related]
16. Functional Polymorphism in the Interleukin 6 (IL6) Gene with Respect to Depression Induced in the Course of Interferon-α and Ribavirin Treatment in Chronic Hepatitis Patients.
Frydecka D; Pawłowski T; Pawlak D; Małyszczak K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):169-175. PubMed ID: 28083615
[TBL] [Abstract][Full Text] [Related]
17. Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
Berenguer J; González-García J; López-Aldeguer J; Von-Wichmann MA; Quereda C; Hernando A; Sanz J; Tural C; Ortega E; Mallolas J; Santos I; Miralles P; Montes ML; Bellón JM; Esteban H;
J Antimicrob Chemother; 2009 Jun; 63(6):1256-63. PubMed ID: 19363085
[TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
Udina M; Moreno-España J; Navinés R; Giménez D; Langohr K; Gratacòs M; Capuron L; de la Torre R; Solà R; Martín-Santos R
Psychoneuroendocrinology; 2013 Sep; 38(9):1803-13. PubMed ID: 23571152
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.
Sulkowski MS; Sherman KE; Dieterich DT; Bsharat M; Mahnke L; Rockstroh JK; Gharakhanian S; McCallister S; Henshaw J; Girard PM; Adiwijaya B; Garg V; Rubin RA; Adda N; Soriano V
Ann Intern Med; 2013 Jul; 159(2):86-96. PubMed ID: 23685940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
